510(k) K940374
K940374 is an FDA 510(k) premarket notification submitted by Seradyn, Inc. for the device "QMS CARBAMAZEPINE ASSAY". The FDA issued a decision of Substantially Equivalent on Jun 2, 1994. The device falls under product code KLT (Enzyme Immunoassay, Carbamazepine), a Class II device regulated under 21 CFR 862.3645. Seradyn, Inc. has 29 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 2, 1994
- Date Received
- Jan 26, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Carbamazepine
- Device Class
- Class II
- Regulation Number
- 862.3645
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Seradyn, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.